Wellcome Sanger Institute to Close Animal Facility

The move reflects scientists using more cell lines and organoids in genetic research, although some experts disagree with the decision to scale back the use of animal models.

Written byChia-Yi Hou
| 1 min read
Wellcome sanger institute genome campus closing animal mouse facility laboratory

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: Sanger Institute and Hinxton Hall, Cambridge, UK
WIKIMEDIA, MAGNUS MANSKE

The Wellcome Sanger Institute announced on May 16 that it would be closing its animal facility, which provides mice, zebrafish, rats, and frogs to geneticists at the institute and internationally, reports Nature. The facility has been open for 13 years and has a staff of 70 people.

The institute states that the closure is related to the growing use of cell lines and organoids, instead of animals. “This decision has been driven by the institute’s scientific strategy,” says director Mike Stratton to Nature. Some researchers in individual labs will be able to use mice on-site until 2022 at the latest.

Scientists at the institute sent an open letter to the institute’s chief operating officer in November 2018 regarding their concerns about animal welfare in the facility, but a Sanger spokesperson says the closure is not related to welfare issues, according ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies